Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Vectura Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Vectura Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Vectura Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Vectura Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Vectura Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Vectura Group Plc, Medical Equipment, Deal Details 11
Asset Purchase 11
SkyePharma Acquires Novel Inhaled Therapy Platform from Pulmagen Therapeutics 11
Partnerships 12
Ablynx Exercises Option for Licensing Agreement with Vectura 12
Vectura Enters into Agreement with Dynavax Technologies 13
Vectura Enters into Co-Development Agreement with Propeller Health 14
Activaero Enters Into Distribution Agreement With Vivisol For Akita Jet Inhalation System 15
Vectura, Tianjin KingYork Group And Zendex Bio Strategy Form Respiratory Joint Venture In China 16
Activaero Enters Into Co-Development Agreement With TransMIT 17
Merger 18
SkyePharma Merges with Vectura 18
Equity Offering 20
SkyePharma Completes Private Placement Of Shares For US$187 Million 20
SkyePharma Completes Rights Offering Of Shares 21
Vectura Group Completes Private Placement Of Shares For US$46 Million 22
Acquisition 23
GlaxoSmithKline May Acquire Vectura for USD1.62 Billion 23
Vectura Acquires Activaero, Medical Device Company, For US$181 Million 24
Vectura Group Plc – Key Competitors 26
Vectura Group Plc – Key Employees 27
Vectura Group Plc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Financial Announcements 29
Sep 11, 2018: Vectura Group: Interim Results 29
Mar 21, 2018: Vectura Group: 2017 Preliminary Results 38
Mar 21, 2018: Vectura Group: 2017 Preliminary Results – Performance in-line with expectations, with strong in-market growth from key inhaled products 39
Sep 06, 2017: Vectura Group: 2017 Interim Results 41
Mar 21, 2017: Vectura Group: Preliminary Results for the nine-month period ended 31 December 2016 43
Mar 21, 2017: Vectura Group Announces Preliminary Results for the nine-month period ended 31 December 2016 45
Corporate Communications 46
Jul 16, 2018: Vectura Appoints Paul Fry as Chief Financial Officer and Executive Director 46
Jun 01, 2018: Vectura Group Appoints Anne Whitaker As Non-Executive Director 47
Apr 20, 2018: Vectura Announces Senior Management Change 48
Apr 20, 2018: Vectura Group: Directorate Change – Chief Financial Officer 49
Nov 29, 2017: Vectura Group appoints Juliet Thompson to its Board of Directors 50
Mar 06, 2017: Vectura Group: Board Change 51
Other Significant Developments 52
Feb 16, 2017: Vectura achieves £9 million royalty cap from GSK Ellipta® products 52
Jan 25, 2017: Seebri / Ultibro Breezhaler 2016 sales reach $512 million triggering $5 million milestone receipt 53
Jan 11, 2017: Vectura Group: Pre-close update 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
Vectura Group Plc, Medical Equipment, Key Facts, 2017 2
Vectura Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Vectura Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Vectura Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Vectura Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Vectura Group Plc, Deals By Market, 2012 to YTD 2018 9
Vectura Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
SkyePharma Acquires Novel Inhaled Therapy Platform from Pulmagen Therapeutics 11
Ablynx Exercises Option for Licensing Agreement with Vectura 12
Vectura Enters into Agreement with Dynavax Technologies 13
Vectura Enters into Co-Development Agreement with Propeller Health 14
Activaero Enters Into Distribution Agreement With Vivisol For Akita Jet Inhalation System 15
Vectura, Tianjin KingYork Group And Zendex Bio Strategy Form Respiratory Joint Venture In China 16
Activaero Enters Into Co-Development Agreement With TransMIT 17
SkyePharma Merges with Vectura 18
SkyePharma Completes Private Placement Of Shares For US$187 Million 20
SkyePharma Completes Rights Offering Of Shares 21
Vectura Group Completes Private Placement Of Shares For US$46 Million 22
GlaxoSmithKline May Acquire Vectura for USD1.62 Billion 23
Vectura Acquires Activaero, Medical Device Company, For US$181 Million 24
Vectura Group Plc, Key Competitors 26
Vectura Group Plc, Key Employees 27
Vectura Group Plc, Subsidiaries 28
List of Figures
Vectura Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Vectura Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Vectura Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Vectura Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Vectura Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Vectura Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Vectura Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Vectura Group Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9